Clinical Trial Update: A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase III study evaluating Ivonescimab plus chemotherapy with or without AK117 in metastatic pancreatic cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• AK117 (AK117)
• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Akeso | Conditions: Pancreatic Cancer | Phase 3 | Status: RECRUITING